Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer
Authors
Keywords
Overall Survival, Residual Disease, Epithelial Ovarian Cancer, Overall Response Rate, Platinum Compound
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 22, Issue S3, Pages 971-978
Publisher
Springer Nature
Online
2015-05-27
DOI
10.1245/s10434-015-4623-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer
- (2014) Barry Rosen et al. GYNECOLOGIC ONCOLOGY
- Primary debulking surgery for advanced ovarian cancer: Are you a believer or a dissenter?
- (2014) John O. Schorge et al. GYNECOLOGIC ONCOLOGY
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy
- (2013) M. Petrillo et al. ANNALS OF SURGICAL ONCOLOGY
- Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
- (2013) Hannah S. van Meurs et al. EUROPEAN JOURNAL OF CANCER
- Fertility preserving treatments for endometrial cancer: The unanswered questions
- (2013) Walter H. Gotlieb GYNECOLOGIC ONCOLOGY
- Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
- (2013) Suk-Joon Chang et al. GYNECOLOGIC ONCOLOGY
- Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study
- (2013) Carsten Lindberg Fagö-Olsen et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
- (2012) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer
- (2011) Melissa M. Thrall et al. GYNECOLOGIC ONCOLOGY
- An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
- (2011) Dennis S. Chi et al. GYNECOLOGIC ONCOLOGY
- Evolution of platinum resistance in high-grade serous ovarian cancer
- (2011) Susanna L Cooke et al. LANCET ONCOLOGY
- The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the Society of Gynecologic Oncologists
- (2010) Summer B. Dewdney et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations
- (2008) David S.P. Tan et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now